论文部分内容阅读
目的对莫尼地平联合依达拉奉治疗高血压脑出血的临床疗效进行观察探讨.方法将我院2013年1月-2014年5月收治的86例高血压脑出血患者随机分为治疗组和对照组,对照组采取常规治疗.治疗组则在常规治疗的基础上加用依达拉奉和尼莫地平.然后对两组的临床疗效进行对比分析.结果治疗组治疗前后的血肿体积、水肿体积、血浆内皮素等存在显著差异.P<0.05.具有统计学意义.治疗组的临床疗效要明显好于对照组的.治疗组的总有效率为83.72%,而对照组的总有效率为67.44%.结论尼莫地平联合依达拉奉治疗高血压脑出血能显著提高临床聊下.具有非常高的临床应用和推广价值。
Objective To observe the curative effect of monodipine and edaravone on hypertensive intracerebral hemorrhage.Methods 86 cases of hypertensive intracerebral hemorrhage admitted in our hospital from January 2013 to May 2014 were randomly divided into treatment group The control group and the control group were given routine treatment.The treatment group was treated with edaravone and nimodipine on the basis of conventional treatment.And then the clinical efficacy of the two groups were compared and analyzed.Results The volume and edema of hematoma in the treatment group before and after treatment Volume, plasma endothelin and other significant differences P <0.05 with statistical significance.The clinical efficacy of treatment group was significantly better than the control group.The total effective rate of the treatment group was 83.72%, while the control group, the total effective rate was 67.44% .Conclusion Nimodipine combined with edaravone in the treatment of hypertensive intracerebral hemorrhage can significantly improve the clinical chat, has a very high clinical application and promotion value.